Director/PDMR Shareholding

Summary by AI ^BETAClose X

Smith & Nephew plc announced on April 16, 2026, that awards of ordinary shares were granted on April 15, 2026, under the company's RISE Share Plan. These awards, valued at nil cost, were made to persons discharging managerial responsibilities (PDMRs), including the Chief Executive Officer and Chief Financial Officer, with each receiving 50 ordinary shares of US$0.20 each. This notification is an initial disclosure under the UK Market Abuse Regulation.

Disclaimer*

Smith & Nephew Plc

16 April 2026

SMITH & NEPHEW PLC

16 April 2026

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

AWARD MADE UNDER THE SMITH & NEPHEW PLC RISE SHARE PLAN

As a part of RISE strategy, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted on 15 April 2026, under the Company's RISE Share Plan, a sub-plan of the Smith & Nephew plc Restricted Share Plan 2024.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc Ordinary Shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Awards granted on 15 April 2026 under the Smith & Nephew plc RISE Share Plan.
Date of Transaction	2026 - 04 - 15
Place of Transaction	Grant took place outside a trading venue

Name (Position)	Status	Price (£)	Volume	Aggregated information
Deepak Nath (Chief Executive Officer)	PDMR	Nil	50	N/A Single Transaction
John Rogers (Chief Financial Officer)	PDMR	Nil	50	N/A Single Transaction
Helen Barraclough (Group General Counsel and Company Secretary)	PDMR	Nil	50	N/A Single Transaction
Paul Connolly (President, Global Operations)	PDMR	Nil	50	N/A Single Transaction
Ajay Dhankhar (Chief Strategy & Corporate Development Officer)	PDMR	Nil	50	N/A Single Transaction
Craig Gaffin (President Global Orthopaedics)	PDMR	Nil	50	N/A Single Transaction
Rohit Kashyap (President AWM and Global Commercial Operations)	PDMR	Nil	50	N/A Single Transaction
Mizanu Kebede (Chief Quality & Regulatory Affairs Officer)	PDMR	Nil	50	N/A Single Transaction
Elga Lohler (Chief HR Officer)	PDMR	Nil	50	N/A Single Transaction
Vasant Padmanabhan (President Research & Development, ENT & Emerging Markets)	PDMR	Nil	50	N/A Single Transaction
Alison Parkes (Chief Compliance Officer)	PDMR	Nil	50	N/A Single Transaction
Scott Schaffner (Global President Sports Medicine)	PDMR	Nil	50	N/A Single Transaction

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END